Hunter Reese

Scientist II at Asklepios Biopharmaceutical

Speaker

Hunter Reese has worked in both downstream process development and MSAT at Asklepios Biopharmaceutical, a gene therapy company. He has experience with AskBio’s platform development method, DoE development strategies, gene therapy scale up activities, and tech transfer to manufacturing. He has worked with several different recombinant adeno-associated virus serotypes and target indications. He previously worked at KBI Biopharma on a variety of protein therapeutics, and he earned his PhD at NC State University on work developing and characterizing affinity resins for Fc-containing products.